1. Home
  2. SGHT

as 07-23-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medical Specialities

Nasdaq

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Founded: 2011 Country:
United States
United States
Employees: N/A City: MENLO PARK
Market Cap: 318.4M IPO Year: 2021
Target Price: $5.60 AVG Volume (30 days): 285.3K
Analyst Decision: Hold Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.12 EPS Growth: N/A
52 Week Low/High: $1.04 - $9.31 Next Earning Date: 08-01-2024
Revenue: $81,496,000 Revenue Growth: 8.27%
Revenue Growth (this year): 5.49% Revenue Growth (next year): 12.42%

SGHT Daily Stock ML Predictions

Stock Insider Trading Activity of Sight Sciences Inc. (SGHT)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Park Sam Boong SGHT Chief Operating Officer Jul 2 '24 Sell $6.21 3,525 $21,897.30 258,229 SEC Form 4
HAYDEN JEREMY B. SGHT Chief Legal Officer Jul 2 '24 Sell $6.21 5,055 $31,401.66 163,565 SEC Form 4
Badawi Paul SGHT President and CEO Jul 1 '24 Sell $6.42 12,569 $80,655.27 5,738,160 SEC Form 4
Badawi David SGHT Chief Technology Officer Jul 1 '24 Sell $6.42 3,128 $20,072.38 1,759,648 SEC Form 4
Bauerlein Alison SGHT Chief Financial Officer May 17 '24 Sell $5.42 13,066 $70,869.98 413,182 SEC Form 4
Bauerlein Alison SGHT Chief Financial Officer Apr 3 '24 Sell $5.08 10,123 $51,414.72 426,248 SEC Form 4
Badawi David SGHT Chief Technology Officer Apr 3 '24 Sell $5.08 3,128 $15,887.11 1,762,776 SEC Form 4
HAYDEN JEREMY B. SGHT Chief Legal Officer Apr 3 '24 Sell $5.08 4,893 $24,851.55 168,620 SEC Form 4
Badawi Paul SGHT President and CEO Apr 3 '24 Sell $5.08 12,571 $63,848.11 5,750,729 SEC Form 4
Park Sam Boong SGHT Chief Operating Officer Apr 3 '24 Sell $5.08 3,414 $17,339.71 261,754 SEC Form 4
Park Sam Boong SGHT Chief Operating Officer Jan 17 '24 Sell $5.16 5,443 $28,107.65 100,735 SEC Form 4
Badawi Paul SGHT President and CEO Jan 17 '24 Sell $5.16 15,917 $82,195.39 5,319,539 SEC Form 4
Badawi David SGHT Chief Technology Officer Jan 17 '24 Sell $5.16 3,414 $17,629.90 1,642,157 SEC Form 4
HAYDEN JEREMY B. SGHT Chief Legal Officer Jan 17 '24 Sell $5.16 4,538 $23,434.23 10,318 SEC Form 4
D1 Capital Partners L.P. SGHT 10% Owner Dec 27 '23 Sell $5.86 2,852,036 $16,712,930.96 3,000,000 SEC Form 4
Encrantz Staffan SGHT Director10% Owner Nov 29 '23 Buy $3.50 3,223 $11,280.50 871,373 SEC Form 4
Encrantz Staffan SGHT Director10% Owner Nov 29 '23 Buy $3.46 140,777 $486,637.93 1,012,150 SEC Form 4
Encrantz Staffan SGHT Director10% Owner Nov 24 '23 Buy $3.09 21,855 $67,427.05 368,150 SEC Form 4
Encrantz Staffan SGHT Director10% Owner Nov 24 '23 Buy $3.31 246,331 $815,946.80 614,481 SEC Form 4
Encrantz Staffan SGHT Director10% Owner Nov 20 '23 Buy $2.25 79,234 $178,189.34 236,733 SEC Form 4
Encrantz Staffan SGHT Director10% Owner Nov 20 '23 Buy $2.48 68,477 $169,535.36 305,210 SEC Form 4
Encrantz Staffan SGHT Director10% Owner Nov 20 '23 Buy $2.50 41,085 $102,708.39 346,295 SEC Form 4
Encrantz Staffan SGHT Director10% Owner Nov 14 '23 Buy $2.00 3,462 $6,913.61 30,496 SEC Form 4

Share on Social Networks: